A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
Clinical trial NCT02763579 · COMPLETED
Trial details
- NCT number
- NCT02763579
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-07
- Primary completion
- 2018-04-24
- Enrollment
- 503
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.